MétaCan
Menu
Back to cohort
Record W2052524261 · doi:10.1093/neuonc/nou273.6

RM-06 * IN VITRO CLONAL EVOLUTION OF GLIOBLASTOMA (GBM) BRAIN TUMOUR INITIATING CELLS (BTIC) TO MODEL TUMOUR RECURRENCE

2014· article· en· W2052524261 on OpenAlexaff
Maleeha Qazi, Parvez Vora, C. Venugopal, Nicole McFarlane, Robin Hallett, Sheila K. Singh

Bibliographic record

VenueNeuro-Oncology · 2014
Typearticle
Languageen
FieldMedicine
TopicCancer Cells and Metastasis
Canadian institutionsMcMaster UniversityOntario Institute for Cancer Research
Fundersnot available
KeywordsTemozolomideBiologySomatic evolution in cancerTranscriptomeSOX2Stem cellGlioblastomaCancer researchRadiation therapyGenetic heterogeneityCancer stem cellBrain tumorOncologyInternal medicinePathologyMedicineCancerGenePhenotypeGene expressionGenetics

Abstract

fetched live from OpenAlex

Glioblastoma (GBM) is the most common and highly aggressive primary adult brain tumour. Despite multimodal therapy, patients on average experience relapse at 9 months and median survival rarely extends beyond 15 months. Targeting the cells that drive GBM formation as well as its inevitable and rapid recurrence has remained a major challenge, likely due to intra-tumoral heterogeneity. At the genetic level, this heterogeneity has prompted a molecular classification of GBM based on differential transcriptome profiling by TCGA. At the cellular level, this heterogeneity may be explained by the existence of multiple subpopulations of cancer cells that have acquired stem cell properties, termed brain tumour initiating cells (BTICs). We postulate that different BTIC subpopulations are capable of first initiating the tumor, and later evading therapy to seed the tumor relapse or recurrence, as they undergo clonal evolution over time in response to various environmental cues including chemotherapy and radiotherapy. In this study, we developed a novel in vitro BTIC model to profile the clonal evolution of treatment naïve GBM BTICs through therapy (temozolomide and radiation treatment) based on transcriptome analysis, stem cell assays and BTIC protein marker expression (CD133, CD15, Sox2 and Bmi1). The expression profile of in vitro treated GBM was compared to recurrent GBM patient samples to determine if our model recapitulated clonal BTIC evolution as seen in patients. Profiling the dynamic nature of BTICs and their evolution over the course of treatment and tumour progression may offer novel therapeutic targets for the treatment of primary and recurrent GBM.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.003
Threshold uncertainty score0.006

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.023
GPT teacher head0.298
Teacher spread0.275 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2014
Admission routes1
Has abstractyes

Explore more

Same venueNeuro-OncologySame topicCancer Cells and MetastasisFrench-language works237,207